Document Detail


Trastuzumab treatment for breast cancer during pregnancy.
MedLine Citation:
PMID:  18208949     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
QUESTION: One of my patients has been diagnosed with breast cancer and started treatment with trastuzumab. She has recently discovered that she is pregnant and wishes to continue the pregnancy. What are the consequences of trastuzumab treatment during pregnancy and can she continue her pregnancy?
ANSWER: Human data regarding the safety of trastuzumab during pregnancy are scarce. Only 3 case reports could be located in the published literature. Anhydramnios was observed in a case where the exposure to trastuzumab occurred during the second trimester, which reversed after discontinuation of the drug without any apparent consequences to the baby. Evidence is insufficient to provide any recommendations, but in light of the case reports, pregnancies exposed to trastuzumab during the second trimester should be closely followed with particular attention to amniotic fluid volume.
Authors:
Alon Shrim; Facundo Garcia-Bournissen; Cynthia Maxwell; Dan Farine; Gideon Koren
Related Documents :
8776369 - Pruritic urticarial papules and plaques of pregnancy (polymorphic eruption of pregnancy...
25193999 - Delusion of pregnancy: an unusual symptom in the context of dementia.
15121619 - Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal m...
15005589 - Pregnancy-related papillophlebitis.
7611049 - Correlation of prenatal events with the development of polymicrogyria.
25364259 - Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report.
2607739 - Detection of early pregnancy factor in superovulated mice.
11005389 - Unintended pregnancy and women's use of prenatal care in ecuador.
14969589 - Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human s...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Canadian family physician Médecin de famille canadien     Volume:  54     ISSN:  1715-5258     ISO Abbreviation:  Can Fam Physician     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-22     Completed Date:  2008-02-07     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0120300     Medline TA:  Can Fam Physician     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  31-2     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Antibodies, Monoclonal / administration & dosage,  therapeutic use*
Antibodies, Monoclonal, Humanized
Antineoplastic Agents / administration & dosage,  therapeutic use*
Breast Neoplasms / drug therapy*
Drug Administration Schedule
Female
Gestational Age
Haplorhini
Humans
Infant, Newborn
Pregnancy
Pregnancy Complications, Neoplastic / drug therapy*
Pregnancy Outcome
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antibodies, Monoclonal, Humanized; 0/Antineoplastic Agents; P188ANX8CK/trastuzumab
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A case of mirtazapine-induced spontaneous orgasms in a female patient.
Next Document:  Folic acid and prevention of neural tube defects.